E. Ohman J:or Asset Management’s Biogen BIIB Stock Holding History

E. Ohman J:or Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Hold	4,819	–	–	0.02%	289
2026 Q1	$883K	Sell	4,819 -900	-16%	-$166K	0.02%	300
2025 Q4	$1.01M	Sell	5,719 -680	-11%	-$111K	0.02%	298
2025 Q3	$896K	Hold	6,399	–	–	0.02%	291
2025 Q2	$804K	Hold	6,399	–	–	0.02%	302
2025 Q1	$876K	Hold	6,399	–	–	0.02%	289
2024 Q4	$979K	Buy	6,399 +800	+14%	+$135K	0.02%	287
2024 Q3	$1.09M	Sell	5,599 -500	-8%	-$105K	0.03%	247
2024 Q2	$1.41M	Sell	6,099 -18,000	-75%	-$3.91M	0.04%	207
2024 Q1	$5.2M	Buy	24,099 +18,500	+330%	+$4.33M	0.13%	86
2023 Q4	$1.45M	Sell	5,599 -900	-14%	-$221K	0.05%	180
2023 Q3	$1.67M	Sell	6,499 -400	-6%	-$107K	0.06%	166
2023 Q2	$1.97M	Buy	6,899 +600	+10%	+$179K	0.07%	150
2023 Q1	$1.75M	Hold	6,299	–	–	0.07%	165
2022 Q4	$1.74M	Hold	6,299	–	–	0.08%	157
2022 Q3	$1.68M	Sell	6,299 -700	-10%	-$149K	0.08%	151
2022 Q2	$1.43M	Hold	6,999	–	–	0.06%	180
2022 Q1	$1.47M	Hold	6,999	–	–	0.05%	213
2021 Q4	$1.68M	Hold	6,999	–	–	0.05%	223
2021 Q3	$1.98M	Buy	6,999 +800	+13%	+$262K	0.06%	175
2021 Q2	$2.15M	Hold	6,199	–	–	0.07%	167
2021 Q1	$1.73M	Sell	6,199 -200	-3%	-$53.9K	0.06%	174
2020 Q4	$1.57M	Sell	6,399 -500	-7%	-$129K	0.06%	165
2020 Q3	$1.96M	Sell	6,899 -200	-3%	-$55.8K	0.1%	124
2020 Q2	$1.9M	Buy	7,099 +500	+8%	+$150K	0.11%	112
2020 Q1	$2.09M	Sell	6,599 -2,800	-30%	-$850K	0.15%	85
2019 Q4	$2.79M	Buy	9,399 +499	+6%	+$138K	0.15%	88
2019 Q3	$2.07M	Buy	8,900 +500	+6%	+$116K	0.13%	103
2019 Q2	$1.96M	Sell	8,400 -42,498	-83%	-$9.81M	0.13%	95
2019 Q1	$12M	Sell	50,898 -10,438	-17%	-$3.29M	0.81%	31
2018 Q4	$18.5M	Buy	61,336 +9,918	+19%	+$3.17M	1.34%	23
2018 Q3	$18.2M	Sell	51,418 -9,135	-15%	-$3.15M	1.17%	23
2018 Q2	$17.6M	Buy	60,553 +11,592	+24%	+$3.26M	1.25%	22
2018 Q1	$13.4M	Sell	48,961 -188	-0.4%	-$58.4K	1.07%	25
2017 Q4	$15.7M	Buy	49,149 +3,363	+7%	+$1.08M	1.27%	21
2017 Q3	$14.3M	Buy	45,786 +96	+0.2%	+$28.4K	1.27%	23
2017 Q2	$12.4M	Buy	45,690 +23,267	+104%	+$6.15M	1.25%	21
2017 Q1	$6.13M	Buy	22,423 +2,970	+15%	+$840K	0.75%	31
2016 Q4	$5.52M	Buy	19,453 +1,488	+8%	+$441K	0.77%	32
2016 Q3	$5.62M	Buy	17,965 +13,665	+318%	+$4.05M	0.84%	29
2016 Q2	$1.04M	Hold	4,300	–	–	0.17%	105
2016 Q1	$1.12M	Hold	4,300	–	–	0.2%	92
2015 Q4	$1.32M	Hold	4,300	–	–	0.23%	88
2015 Q3	$1.25M	Sell	4,300 -600	-12%	-$198K	0.34%	64
2015 Q2	$1.98M	Sell	4,900 -400	-8%	-$161K	0.46%	50
2015 Q1	$2.24M	Hold	5,300	–	–	0.52%	47
2014 Q4	$1.81M	Hold	5,300	–	–	0.43%	52
2014 Q3	$1.75M	Hold	5,300	–	–	0.43%	50
2014 Q2	$1.67M	Hold	5,300	–	–	0.41%	53
2014 Q1	$1.62M	Sell	5,300 -700	-12%	-$222K	0.4%	54
2013 Q4	$1.68M	Sell	6,000 -200	-3%	-$51.7K	0.4%	54
2013 Q3	$1.49M	Buy	6,200 +400	+7%	+$89.5K	0.38%	56
2013 Q2	$1.25M	Buy	+5,800	New	+$1.24M	0.34%	59

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

E. Ohman J:or Asset Management's BIIB Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its Biogen (BIIB) position steady in Q2 2026 at 4,819 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #289.

E. Ohman J:or Asset Management first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.5M in Q4 2018. 621 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

E. Ohman J:or Asset Management held 4,819 shares of Biogen worth $1.04M as of Q2 2026.
E. Ohman J:or Asset Management left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.02% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #289 holding.
E. Ohman J:or Asset Management first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
E. Ohman J:or Asset Management's Biogen position peaked at $18.5M in Q4 2018.
621 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.